About Us

Our Mission

Up until now, obtaining reliable test results for COVID-19 took multiple days, putting thousands of lives in limbo and creating bottlenecks in labs. Thanks to our gold standard rapid PCR-based tests, people know within a short time if they are safe to travel, work, be with their families and participate in society.

Let’s beat this pandemic, let’s return to normal!

Our Company

We are a Swiss company headquartered in Bern, specialized in developing molecular diagnostic test kits for the detection of infectious COVID-19 positive carriers. We are an international company, with a US subsidiary in Miami.

Our focus is developing rapid molecular diagnostic test kits for an accurate detection of SARS-CoV-2, the virus causing COVID-19. Our products, developed and made in Switzerland, allow for the mass testing of all individuals who can spread the virus and accelerate the pandemic.

The name “ender” comes from the Bernese Swiss German expression, Dr Ender isch dr Gschwinder, meaning that “the fastest one is first”. It encapsulates our company’s action of responding early to the COVID-19 health crisis and being fast in delivering reliable results.

We offer a cutting-edge solution for an effective management of the COVID-19 pandemic with on-site or laboratory diagnosis.

Our Team

Our team has extensive experience in biotechnology, with a strong focus on developing molecular biological rapid tests for infectious diseases.

CEO

Paul Senn

COO

Matthias Peterhans

CMO

Heidi Horsch

CFO

Lars Birkmann

CTO

Alexander Lüthi

CSO

Samuel Zürcher

CCO

Roland K. Hilgers

Our History

The founders of ender diagnostics met during their work in the clinical science setup at the Institute for Infectious Diseases of the University of Bern. While conducting research and developing their projects, the founders faced a burning issue: the procedures in the field were taking too long to deliver reliable results. With a desire to improve laboratory work, they developed and patented a technology of isothermal polymerase chain reaction for the rapid detection of pathogens.

With this new technology in the research phase, they founded their first company, certus diagnostics, in 2017. With the isothermal PCR the new products achieved a reliable result in just 30 minutes. The focus of certus diagnostics lies on the laboratory setup, mainly the development of quality control in labs.

As this technology was promising for multiple business applications, it was transferred into the veterinary field. The second company, livet, was founded in July 2019. It specializes in molecular diagnostic test kits for the detection of infectious diseases in animals.

In winter 2020, the normal course of life was interrupted by the hit of the COVID-19 pandemic. Immediately responding to the new circumstance, ender diagnostics was founded in April 2020. A transfer of the isothermal amplification technology from a veterinary to human diagnostics application quickly emerged. The company developed two new test kits specifically designed for the detection of the SARS-CoV-2 virus.

2006
 

Basic Research
University

March
2017

University to Laboratory

July
2019

Laboratory to Animal

April
2020

Animal to Human

Do your part in the fight against the COVID-19 pandemic and join our team!

We have created a highly professional work environment where trust, community and good time are a must. We are always looking for dedicated and innovative team members to help us move forward and achieve our mission.